Innovation in Strategic Alliances: Moving from Transactional Outsourcing to a Partnership

Life Sciences, Pharmaceutical, Commercialization & HEOR,
  • Wednesday, June 25, 2014

drugs-around-the-world-1Outsourcing in the clinical development industry has continued to evolve toward partnerships and strategic alliances. This webinar focuses on the relationship between Infinity Pharmaceuticals and INC Research as a case study in how Pharma and CROs can successfully make this transition.

Representatives from Infinity and INC will discuss how they have evolved to a partnership model, the drivers for change and what it takes to establish the foundation of a successful partnership. Other topics will include relationship management, effective oversight and key aspects of governance necessary for a relationship to thrive.


Maria Makarovskaya, Clinical Outsourcing Lead, Infinity Pharmaceuticals

Maria Makarovskaya has 18 years of experience in clinical business operations in Pharmaceutical/Biotech industry. Areas of expertise include: strategic outsourcing, contract management, financial analysis, global procurement and project management with emphasis on clinical research. She started her career at a site at Rhode Island Hospital and continued at various Pharmaceutical and device companies, including Vertex Pharmaceuticals, Sepracor, Molecular Insight Pharmaceuticals, Boston Scientific and Cubist.

She holds a Master’s Degree in Education and Linguistics from Moscow Linguistic University and Paralegal Diploma from National Academy for Paralegal Studies from Albertus Magnus College, CT.

Currently Maria is heading Clinical Outsourcing at Infinity Pharmaceuticals.

Message Presenter

David Burnham, Vice President, Strategic Alliances, INC Research

David Burnham serves as Vice President, Strategic Alliances at INC Research, where he is responsible for developing and nurturing strategic relationships between customers and the CRO. Throughout his 17 years in the industry at CRO, large and small pharma he has worked on Phase I to IV trials, and has significant experience in running global programs in accordance with ICH-GCP from IND to product approval and understands that this cannot be achieved without effective partnerships. David has leveraged his previous experience while at INC Research as the Vice President Strategic Alliance Management to implement a mutually beneficial partnership model with Infinity Pharmaceuticals and move from transactional outsourcing to partnership.

Message Presenter

Who Should Attend?

The target audience includes individuals in operational, outsourcing, CRO oversight or governance roles at pharmaceutical companies.

Xtalks Partner

INC Research

INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. The company’s The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit

Media Partner

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account